Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 104.88 | 128.52 | 124.90 | 132.71 |
Total Revenue | 104.88 | 128.52 | 124.90 | 132.71 |
Costof Revenue Total | 75.26 | 104.38 | 92.26 | 96.85 |
Gross Profit | 29.62 | 24.14 | 32.64 | 35.86 |
Selling/ General/ Admin Expenses Total | 15.15 | 20.09 | 15.08 | 14.09 |
Depreciation/ Amortization | 3.29 | 3.33 | 2.94 | 1.91 |
Unusual Expense( Income) | 0.00 | 1.05 | - | - |
Other Operating Expenses Total | 14.95 | 7.58 | 16.93 | 13.39 |
Total Operating Expense | 108.65 | 136.42 | 127.21 | 126.25 |
Operating Income | -3.78 | -7.90 | -2.31 | 6.47 |
Interest Inc( Exp) Net- Non- Op Total | -50.50 | -51.62 | -28.58 | -24.79 |
Other Net | 1.64 | 0.68 | 0.07 | 1.51 |
Net Income Before Taxes | -7.18 | -12.39 | -5.02 | 5.53 |
Provisionfor Income Taxes | -1.88 | -3.04 | -1.32 | 0.43 |
Net Income After Taxes | -5.31 | -9.35 | -3.70 | 5.10 |
Net Income Before Extra Items | -5.31 | -9.35 | -3.70 | 5.10 |
Net Income | -5.31 | -9.35 | -3.70 | 5.10 |
Income Availableto Com Excl Extra Ord | -5.31 | -9.35 | -3.70 | 5.10 |
Income Availableto Com Incl Extra Ord | -5.31 | -9.35 | -3.70 | 5.10 |
Diluted Net Income | -5.31 | -9.35 | -3.70 | 5.10 |
Diluted Weighted Average Shares | 4.74 | 4.73 | 4.73 | 4.73 |
Diluted EPS Excluding Extra Ord Items | -1.12 | -1.98 | -0.78 | 1.08 |
Diluted Normalized EPS | -1.12 | -1.83 | -0.79 | 1.07 |
Gain( Loss)on Saleof Assets | - | 0.00 | 0.79 | 0.37 |
Kimia Biosciences Dividend Kimia Biosciences Bonus Kimia Biosciences News Kimia Biosciences AGM Kimia Biosciences Rights Kimia Biosciences Splits Kimia Biosciences Board Meetings Kimia Biosciences Key Metrics Kimia Biosciences Shareholdings Kimia Biosciences Balance Sheet Kimia Biosciences Cashflow Kimia Biosciences Q1 Results Kimia Biosciences Q2 Results Kimia Biosciences Q3 Results Kimia Biosciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks